InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Enyedy Mark J, Chief Executive Officer. Officer active across 1 companies, notably ImmunoGen, Inc.. Cumulatively, 2 disclosures have been recorded. The latest transaction was filed on 30 June 2021 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€17,9193,849 shares@ €4.6556100.0% of flow
Common Stock
SEC:0001179110-21-007317·
€17,9193,849 shares@ €4.655650.0% of flow
Common Stock
SEC:0001179110-21-007317:0·
2 of 2 declarations
About Enyedy Mark J
Mark J. Enyedy is the Chief Executive Officer of ImmunoGen, Inc. He is responsible for the strategic direction and management of the company's operations. His leadership is essential in ensuring growth and innovation at ImmunoGen.
